Market Insider

In this article

A worker assembles a box for delivery at the Amazon fulfillment center in Baltimore, Maryland, U.S., April 30, 2019.
Clodagh Kilcoyne | Reuters

Check out the companies making headlines Thursday after the bell

Amazon — Amazon shares fell more than 6% in after-hours trading after the company reported its first revenue miss in three years and gave weak third-quarter guidance. For the three months ending Sept. 30, Amazon said it expects to book sales between $106 billion and $112 billion, well below consensus estimates of $119.2 billion.

Skyworks Solutions — The California-based semiconductor company reported fiscal third-quarter earnings per share of $2.15, just ahead of the $2.14 per share anticipated by analysts, according to Refinitiv. Revenues also just managed to top estimates. The company’s stock dropped 5% in the overnight session despite the company’s strong fiscal fourth-quarter guidance.

Gilead Sciences — The biopharmaceutical company saw its equity fall just over 2% even after it leapt to a profit in the second quarter. Gilead said its sales increase 21% thanks to demand for its therapies like Covid-19 treatment remdesivir and its hepatitis C virus products. Its net profit was $1.52 billion for the quarter, compared with a loss of $3.34 billion a year earlier.

T-Mobile — Shares of T-Mobile dipped more than 2% in extended trading after the telecommunication company posted a modest beat on revenues during the second quarter. Sales increased 13% to $19.95 billion compared with the $19.34 billion expected by analysts polled by Refinitiv.

Pinterest — Pinterest shares tanked 16% in extended trading after the social media service reported monthly active user figures below Wall Street’s expectations for its second-quarter earnings. The company also said it expects that third-quarter revenues will grow in the “low-40% range” year over year, below where some analysts had forecast.

Articles You May Like

AI’s Dark Horse Could Become Its Crown Jewel Under Trump
Hedge funds performed better under Democratic presidents than Republican ones, history shows
Trump is the most pro-stock market president in history, Wharton’s Jeremy Siegel says
Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value
Top Wall Street analysts like these dividend-paying stocks